Episode Details

Back to Episodes
Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

Published 5 years, 3 months ago
Description
The bioelectronics industry is poised to take off so we visited with Carolina Aguilar, CEO/Co-founder, INBRAIN Neuroelectronics about the field's potential. Chris Newmarker, executive editor of life sciences at MassDevice, delivers his Newmarker's Newsmakers highlighting news from Dexcom, NeuroMetrix, Nevro, Ancora and the Galien foundation. Subscribe to this podcast on Google, Amazon, Apple, Spotify and other major podcast channels.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us